BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7868660)

  • 1. Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction.
    Tarlatzis BC; Bili H; Bontis J; Lagos S; Vatev I; Mantalenakis S
    Hum Reprod; 1994 Nov; 9(11):1983-6. PubMed ID: 7868660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.
    Ditkoff EC; Sauer MV
    Hum Reprod; 1996 May; 11(5):1035-7. PubMed ID: 8671386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
    Weissman A; Barash A; Shapiro H; Casper RF
    Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
    Feldberg D; Ashkenazi J; Dicker D; Yeshaya A; Goldman GA; Dicker D; Goldman JA
    Fertil Steril; 1989 Jan; 51(1):42-5. PubMed ID: 2521325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ovarian cysts during gonadotrophin-releasing hormone agonists (GnRHa) administration.
    Sampaio M; Serra V; Miro F; Calatayud C; Castellvi RM; Pellicer A
    Hum Reprod; 1991 Feb; 6(2):194-7. PubMed ID: 1905307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization.
    Herman A; Ron-El R; Golan A; Nahum H; Soffer Y; Caspi E
    Fertil Steril; 1990 May; 53(5):854-8. PubMed ID: 2185043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ovarian cysts on the results of in vitro fertilization.
    Parinaud J; Cohen K; Oustry P; Perineau M; Monroziès X; Rème JM
    Fertil Steril; 1992 Dec; 58(6):1174-7. PubMed ID: 1459269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization.
    Zeyneloglu HB; Isik AZ; Kara S; Senöz S; Ozcan U; Gökmen O
    Int J Fertil Womens Med; 1998; 43(6):300-5. PubMed ID: 9920539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation.
    Neuspiller F; Levy M; Remohí J; Ruiz A; Simón C; Pellicer A
    Hum Reprod; 1998 May; 13(5):1148-51. PubMed ID: 9647536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome.
    Ellenbogen A; Abu-Asbah I; Libal Y; Jaschevatzky O; Anderman S; Ballas S
    Gynecol Endocrinol; 1997 Apr; 11(2):101-4. PubMed ID: 9174850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response in repetitive cycles induced by menotrophin alone or combined with gonadotrophin releasing hormone analogue.
    Ron-El R; Raziel A; Herman A; Golan A; Nahum H; Soffer Y; Caspi E
    Hum Reprod; 1990 May; 5(4):427-30. PubMed ID: 2141846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
    Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
    Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment.
    Biljan MM; Lapensée L; Mahutte NG; Bissonnette F; Hemmings R; Tan SL
    Fertil Steril; 2000 Nov; 74(5):941-5. PubMed ID: 11056237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
    Lewit N; Kol S; Manor D; Itskovitz-Eldor J
    Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.